Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin- clindamycin combinations

Journal of Clinical Microbiology

Volumn 48, Issue 6, 2010, Pages 2275-2277

  Bowling, Jason E ^a   Owens, Aaron E ^a,b   McElmeel, M Leticia ^a   Fulcher, Letitia C ^a   Herrera, Monica L ^a   Wickes, Brian L ^a   Jorgensen, James H ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b University Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; BROTH DILUTION; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HEMOLYSIN PROTEINS; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS; TRANSCRIPTIONAL ACTIVATION;

EID: 77952928356     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00663-10     Document Type: Article

References (15)

1. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M07-A8, 8th edition. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing. 19th informational supplement, M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
3. De Mouy, D., J. D. Cavallo, R. Leclercq, and R. Fabre. 2001. Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study. Antimicrob. Agents Chemother. 45:2400-2402.
4. Desjardins, M., K. L. Delgaty, K. Ramotar, C. Seetaram, and B. Toye. 2004. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J. Clin. Microbiol. 42:5620-5623.
5. Diaz, M., M. J. Torres Sanchez, and M. J. Aznar. 2008. Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-hemolytic streptococci of Lancefield groups A, B, C, and G in Seville, Spain. Clin. Micrbiol. Infect. 14:85-87.
6. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
7. Lewis, J. S., II, and J. H. Jorgensen. 2005. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin. Infect. Dis. 40:280-285.
8. Michos, A. G., C. G. Bakoula, M. Braoudaki, F. I. Koutouzi, E. S. Roma, A. Pangalis, G. Nikolopoulou, G. Kirikou, and V. P. Syriopoulou. 2009. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Diagn. Microbiol. Infect. Dis. 64:295-299.
9. Portillo, A., M. Lantero, I. Olarte, F. Ruiz-Larrea, and C. Torres. 2001. MLS resistance phenotypes and mechanisms in beta-haemolytic group B, C and G Streptococcus isolates in La Rioja, Spain. J. Antimicrob. Chemother. 47:115-116.
10. Raney, P. M., F. C. Tenover, R. B. Carey, J. E. McGowan, Jr., and J. B. Patel. 2006. Investigation of inducible clindamycin and telithromycin resistance in isolates of beta-hemolytic streptococci. Diagn. Microbiol. Infect. Dis. 55:213-218.
11. Reig, M., J. C. Galan, F. Baquero, and J. C. Perez-Diaz. 2001. Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: a possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes. Antimicrob. Agents Chemother. 45:630-632. (Pubitemid 32105309)
12. Richter, S. S., K. P. Heilmann, S. E. Beekmann, N. J. Miller, A. L. Miller, C. L. Rice, C. D. Doern, S. A. Reid, and G. V. Doern. 2005. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin. Infect. Dis. 41:599-608.
13. Spellerberg, B., and C. Brandt. 2007. Streptococcus, p. 412-429. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 9th ed. American Society for Microbiology, Washington, DC.
14. Swenson, J. M., W. B. Brasso, M. J. Ferraro, D. J. Hardy, C. C. Knapp, L. K. McDougal, L. B. Reller, H. S. Sader, D. Shortridge, R. Skov, M. P. Weinstein, B. L. Zimmer, and J. B. Patel. 2007. Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycinclindamycin combination wells. J. Clin. Microbiol. 45:3954-3957.
15. York, M. K., L. Gibbs, F. Perdreau-Remington, and G. F. Brooks. 1999. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California. J. Clin. Microbiol. 37:1727-1731.